Pan-Bcl-2 Inhibitor Obatoclax Delays Cell Cycle Progression and Blocks Migration of Colorectal Cancer Cells | PLOS ONE
Drugs and Clinical Approaches Targeting the Antiapoptotic Protein: A Review
Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling | BMC Cancer | Full Text
Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis - Clinical Lymphoma, Myeloma and Leukemia
Obatoclax - an overview | ScienceDirect Topics
Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK | Cell Death & Disease
Obatoclax Mesylate (GX15-070 Mesylate) | Bcl-2 Family Inhibitor | MedChemExpress
OBATOCLAX
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer - Lung Cancer
Obatoclax - LKT Labs
IJMS | Free Full-Text | Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells | HTML
Obatoclax Mesylate (GX15-070 Mesylate) | Bcl-2 Family Inhibitor | MedChemExpress
Obatoclax Mesylate (GX15-070) | ≥99%(HPLC) | Selleck | Bcl-2 antagonist
A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia.
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells | SpringerLink
Pharmacodynamic biomarker analysis from the phase 1 trial of obatoclax... | Download Scientific Diagram
Obatoclax - Wikipedia
Obatoclax Mesylate (GX15-070) | ≥99%(HPLC) | Selleck | Bcl-2 antagonist
Obatoclax mesylate | C21H23N3O4S - PubChem
A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia | PLOS ONE
Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis - Clinical Lymphoma, Myeloma and Leukemia
Obatoclax mesylate (GX15-070) | C21H23N3O4S - PubChem
803712-79-0 Obatoclax mesylate AKSci V2454
Obatoclax mesylate Supplier | CAS 803712-79-0 | GX15-070 | Tocris Bioscience
Obatoclax Induces G1/G0‐Phase Arrest via p38/p21waf1/Cip1 Signaling Pathway in Human Esophageal Cancer Cells - Zhong - 2014 - Journal of Cellular Biochemistry - Wiley Online Library
